Neuroendocrine Carcinoma
📧 Sign up to get email alerts when something new happens for Neuroendocrine Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3) [Phase 2]
Phase 2 trial investigating everolimus with temozolomide in advanced gastroenteropancreatic neuroendocrine carcinoma (G3) has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients [Phase 2]
Phase II study assessing the efficacy and safety of TLC388 in patients with neuroendocrine carcinomas has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating cisplatin and etoposide with or without veliparib in extensive-stage small cell lung cancer has completed recru…
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma [Phase 2]
Phase 2 clinical trial evaluating the effectiveness of SOX as second-line chemotherapy in neuroendocrine carcinoma.
-
CLINICAL_TRIALS research · 2017-06-01Clinical Trial Update: Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma [Phase 2]
A Phase 2 clinical trial update evaluating the FOLFIRI chemotherapy regimen as second-line treatment for Neuroendocrine Carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-11-22Clinical Trial Update: Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans [Phase 1]
Phase I imaging trial evaluating 68Ga-NODAGA-E(cRGDyK)2 PET for assessing angiogenesis in primary and metastatic tumors; trial status is unk…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: 68Ga-DOTATATE PET Scan in Neuroendocrine Cancer [Phase 2]
Results from a Phase 2 trial evaluating 68Ga-DOTATATE PET imaging in neuroendocrine carcinoma have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers [Phase 2]
Phase 2 trial evaluating the combination of bevacizumab, pertuzumab, and octreotide (Sandostatin) for neuroendocrine carcinoma has completed…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome [Phase 2]
A Phase 2 trial of above-label octreotide LAR for insufficiently controlled carcinoid syndrome in neuroendocrine carcinoma was terminated, w…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: TheraSphere for the Treatment of Liver Metastases [Phase 2]
Phase 2 clinical trial update for TheraSphere in treating liver metastases has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating 68Ga-DOTATATE PET imaging in patients with neuroendocrine tumors to assess diagnostic performance.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy [Phase 2]
A Phase 2 clinical trial of antineoplaston therapy for Merkel cell carcinoma, islet cell carcinoma, neuroendocrine carcinoma, and pituitary …
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors [Phase 2]
A Phase 2 trial of irinotecan in patients with advanced neuroendocrine tumors, including carcinoma of unknown primary and neuroendocrine car…
-
CLINICAL_TRIALS trial_result · 2013-05-08Clinical Trial Update: Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma [Phase 2]
Phase 2 trial evaluating Avastin (bevacizumab) with everolimus in advanced low or intermediate grade neuroendocrine carcinoma; results poste…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases [Phase 2]
Phase 2 clinical trial evaluated isolated hepatic perfusion with melphalan for patients with primary unresectable liver cancer or liver meta…
-
CLINICAL_TRIALS trial_result · 2011-08-31Clinical Trial Update: Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma [Phase 2]
An extension study evaluating the safety and efficacy of Atiprimod for neuroendocrine carcinoma has completed its Phase 2 trial.
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 2]
Phase 2 update reporting safety and efficacy of Atiprimod in patients with low to intermediate-grade neuroendocrine carcinoma.